Abstract
The anthrax protective antigen (PA) is the central component of the three-part anthrax toxin, and it is the primary immunogenic component in the approved AVA anthrax vaccine and the "next-generation" recombinant PA (rPA) anthrax vaccines. Animal models have indicated that PA-specific antibodies (AB) are sufficient to protect against infection with Bacillus anthracis. In this study, we investigated the PA domain specificity, affinity, mechanisms of neutralization, and synergistic effects of PA-specific antibodies from a single donor following vaccination with the rPA vaccine. Antibody-secreting cells were isolated 7 days after the donor received a boost vaccination, and 34 fully human monoclonal antibodies (hMAb) were identified. Clones 8H6, 4A3, and 22F1 were able to neutralize lethal toxin (LeTx) both in vitro and in vivo. Clone 8H6 neutralized LeTx by preventing furin cleavage of PA in a dose-dependent manner. Clone 4A3 enhanced degradation of nicked PA, thereby interfering with PA oligomerization. The mechanism of 22F1 is still unclear. A fourth clone, 2A6, that was protective only in vitro was found to be neutralizing in vivo in combination with a toxin-enhancing antibody, 8A7, which binds to domain 3 of PA and PA oligomers...Continue Reading
References
Jul 1, 1988·Infection and Immunity·S F LittleE Cora
May 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·S H Leppla
Feb 27, 1997·Nature·C PetosaR C Liddington
Jul 31, 1998·Vaccine·B E IvinsA M Friedlander
Nov 9, 2001·Nature·K A BradleyJ A Young
Jan 18, 2002·Infection and Immunity·David KobilerZeev Altboum
Jan 16, 2003·Biochemical Pharmacology·Kenneth A Bradley, John A T Young
Mar 21, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Carlos P TabordaArturo Casadevall
Apr 17, 2004·Journal of Immunological Methods·Shane CrottyRafi Ahmed
May 14, 2004·Journal of Immune Based Therapies and Vaccines·Ritsuko Sawada-HiraiAngray S Kang
Oct 11, 2005·Proceedings of the National Academy of Sciences of the United States of America·Vladimir A KarginovSergey M Bezrukov
Feb 3, 2006·The Journal of Infectious Diseases·Zhaochun ChenRobert Purcell
Feb 8, 2006·Biochemical and Biophysical Research Communications·Jun ZhangWei Chen
Feb 7, 2007·Vaccine·Jessica A ChichesterVidadi Yusibov
Mar 6, 2007·Annual Review of Biochemistry·John A T Young, R John Collier
Sep 21, 2007·Human Vaccines·James D CampbellKaren L Kotloff
Feb 21, 2008·Infection and Immunity·Yong Sung ParkTae Woo Kim
Feb 19, 2009·Infection and Immunity·Donald ReasonJianhui Zhou
Feb 28, 2009·Nature Protocols·Kenneth SmithPatrick C Wilson
May 12, 2009·Journal of Virological Methods·Hua-Xin LiaoBarton F Haynes
Aug 12, 2009·Molecular Aspects of Medicine·Fiorella Tonello, Cesare Montecucco
Aug 26, 2009·Infection and Immunity·Cassandra D Kelly-Cirino, Nicholas J Mantis
Jun 11, 2010·The Journal of Infectious Diseases·Sherry R CroweJudith A James
Nov 17, 2010·PloS One·Bruce K BrownMerlin L Robb
Nov 10, 2011·Toxins·Zhaochun ChenRobert Purcell
Mar 20, 2012·Vaccine·Kenneth SmithJudith A James
Jul 25, 2012·Proceedings of the National Academy of Sciences of the United States of America·Arturo Casadevall, Alena Janda
Mar 6, 2013·Protein Expression and Purification·Ju LiuWei Chen
Apr 23, 2013·Cell Host & Microbe·Siu-Kei ChowArturo Casadevall
Aug 30, 2013·Expert Review of Vaccines·Manpreet KaurRakesh Bhatnagar
Dec 7, 2013·Clinical and Vaccine Immunology : CVI·Shipo WuWei Chen
May 9, 2014·Infection and Drug Resistance·Carlos E Kummerfeldt
Citations
Nov 28, 2015·Vaccine·Ryan C McComb, Mikhail Martchenko
Feb 8, 2006·Biochemical and Biophysical Research Communications·Jun ZhangWei Chen
Mar 2, 2016·Toxins·Xiaodong ZaiWei Chen
Nov 1, 2017·Biosensors·Rejane L Petersen
Jan 31, 2019·Frontiers in Immunology·Hemangi B ShahMark L Lang
Jan 3, 2020·Journal of Biomedical Science·Ruei-Min LuHan-Chung Wu
Mar 28, 2020·MAbs·Pengfei FanWei Chen
Dec 29, 2020·International Immunopharmacology·Guanying ZhangWei Chen